Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohort

Author:

Krieger Stephen,Zarif Myassar,Bumstead Barbara,Buhse Marijean,Kaczmarek Olivia,Srinivasan Jared,Barros Nuno,Sima Diana,Ribbens Annemie,Van Hecke Wim,Lewin James B.,Mendoza Jason P.,Gudesblatt Mark

Funder

Biogen

Bristol-Myers Squibb

Publisher

Elsevier BV

Reference9 articles.

1. interpretation and impact of real-world Clinical data for the practicing clinician;Blonde;Adv. Ther.,2018

2. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

3. Characterizing absolute lymphocyte count profiles in dimethyl fumarate’treated patients with MS Patient management considerations;Fox;Neurol. Clin. Pract.,2016

4. Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE;Gold;Ther. Adv. Neurol. Disord.,2020

5. Effects of Dimethyl Fumarate on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: Pooled Analysis Phase 3 DEFINE and CONFIRM Studies;Nakamura;Front. Neurol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3